Intravesical Bcg Therapy in Bladder Carcinoma:Effect on Cytotoxicity, IL-2 Production and Phenotype of Peripheral Blood Mononuclear Cells
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 25 (4) , 269-273
- https://doi.org/10.3109/00365599109024557
Abstract
The purpose of the study was to examine the effects of intravesical BCG treatment on the cytotoxicity, interleukin-2 (IL-2) production and distribution of the subsets of peripheral blood mononuclear cells (PBMC) in patients with carcinoma in situ of the bladder. Treatments were made in 6 patients during a conventional BCG treatment schedule. Four patients showed a complete response, one a partial response and one had a progressive disease after BCG treatment. Intravesical BCG did not induce significant changes in the cytotoxicity of PBMC. The distribution of NK-cells and T-cells also remained unchanged and so did the lectin induced production of IL-2. The results suggest that the effects of intravesical BCG on the immune system should be studied in lymphocytes isolated from the bladder.Keywords
This publication has 14 references indexed in Scilit:
- Reduced LAK cytotoxicity of peripheral blood mononuclear cells in patients with bladder cancer: Decreased LAK cytotoxicity caused by a low incidence of CD56+ and CD57+ mononuclear blood cellsJournal of Clinical Immunology, 1990
- Analysis of mucosal bladder leucocyte subpopulations in patients treated with intravesical Bacillus Calmette-GuerinUrological Research, 1989
- Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-GuérinCancer Immunology, Immunotherapy, 1989
- TCR gamma delta cells--minor redundant T cell subset or specialized immune system component?The Journal of Immunology, 1989
- BCG induced killer cell activityUrological Research, 1988
- Defect in lectin-induced interleukin 2 production by peripheral blood lymphocytes of patients with invasive urinary bladder carcinomaImmunology Letters, 1988
- VLA‐1: a T cell surface antigen which defines a novel late stage of human T cell activationEuropean Journal of Immunology, 1985
- Comparative studies of normal, ‘spontaneously’ transformed and malignant human urothelium cells in vitroEuropean Journal of Cancer and Clinical Oncology, 1983
- Established cell line of urinary bladder carcinoma (T24) containing tumour‐specific antigenInternational Journal of Cancer, 1973